Text size Albert Bourla, CEO of the pharmaceutical company Pfizer Drew Angerer / Getty Images Albert Bourla, Pfizer‘s CEO, he has no patience with the argument that pharmaceutical companies should not make a profit from the drugs and vaccines they introduce to fight Covid-19. “I think it is very bad,” …
Read More »
Text size Photograph by JOSEPH PREZIOSO / AFP via Getty Images The Modern biotechnology company, which has received commitments of nearly $ 1 billion from the federal government to develop its Covid-19 vaccine, seeks to sell the vaccine for between $ 25 and $ 30 per dose, the Financial Times …
Read More »
Text size AMD EPYC processors Courtesy of AMD. Advanced Micro Devices gave investors reason to cheer on Tuesday when it reported earnings that exceeded expectations and said it would sell more chips at a higher profit than anticipated. Shares of AMD (ticker: AMD) rebounded in the extended session, advancing nearly …
Read More »
Text size Digital candles increased 276% in the quarter, while sales in the same store rose 26.5%. Matthew Staver / Bloomberg News Albertsons Cos. He released an optimistic first-quarter fiscal report on Monday, but his shares were falling because investors may have been waiting for more from the supermarket operator, …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna. . That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems …
Read More »